Mono Corax Retard en es it fr

Mono Corax Retard Brand names, Mono Corax Retard Analogs

Mono Corax Retard Brand Names Mixture

  • No information avaliable

Mono Corax Retard Chemical_Formula

C6H9NO6

Mono Corax Retard RX_link

http://www.rxlist.com/cgi/generic/isomono2.htm

Mono Corax Retard fda sheet

http://www.fda.gov/cder/foi/anda/98/75-147_Isosorbide.htm

Mono Corax Retard msds (material safety sheet)

Mono_Corax_Retard MSDS

Mono Corax Retard Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Mono Corax Retard Molecular Weight

191.139 g/mol

Mono Corax Retard Melting Point

88-91oC

Mono Corax Retard H2O Solubility

1.07E+005 mg/L

Mono Corax Retard State

Solid

Mono Corax Retard LogP

-0.15

Mono Corax Retard Dosage Forms

Tablet (immediate release); Tablet (extended release)

Mono Corax Retard Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Mono Corax Retard Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Mono Corax Retard Absorption

100%

Mono Corax Retard side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Mono Corax Retard Patient Information

Mono Corax Retard Organisms Affected

Humans and other mammals